BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, April 7, 2026
Breaking News: Best of BioWorld Science: Q1Breaking News: Best of BioWorld Science: Q1Breaking News: Best of BioWorld Science: Q1
Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic RSS Feed RSS

Alizé Pharma reports data from a Phase Ib trial of AZP-531 in type 2 diabetes

Oct. 30, 2015

Diabetes experts review potential link between SGLT2 inhibitors and diabetic ketoacidosis

Oct. 30, 2015

4-Epi-isofagomine analogue shows promise for GM1-gangliosidosis and morquio syndrome type B

Oct. 28, 2015

Small-molecule Dvl-CXXC5 antagonists show potential for the treatment of osteoporosis

Oct. 28, 2015

Hamni Science discloses cannabinoid CB1 receptor antagonists

Oct. 28, 2015

XOMA starts phase II trial of XOMA-358 in patients with congenital hyperinsulinism

Oct. 27, 2015

FDA approves Strensiq for hypophosphatasia in children

Oct. 26, 2015

FDA advisory committee favors approval of AstraZeneca's lesinurad for hyperuricemia in gout

Oct. 26, 2015

Sanofi develops GDIR agonists

Oct. 23, 2015

HighTide Biopharma starts phase I trial of antidiabetic candidate HTD-4010

Oct. 23, 2015
Previous 1 2 … 356 357 358 359 360 361 362 363 364 … 1789 1790 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 6, 2026.
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • 3D illustration of antibodies

    Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

    BioWorld Science
    Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing